Meta-analysis Reveals the Prognostic Value of Circulating Tumour Cells Detected in the Peripheral Blood in Patients with Non-Metastatic Colorectal Cancer
Abstract Detecting circulating tumour cells (CTCs) is considered as effective and minimally invasive technique to predict the prognosis of patients with metastatic colorectal cancer (CRC), but its clinical validity is still conflicting in patients without metastasis. We performed this meta-analysis...
Guardado en:
Autores principales: | Yan-jun Lu, Peng Wang, Jing Peng, Xiong Wang, Yao-wu Zhu, Na Shen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0ce9e149067247a7bc5662da22bc232f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab
por: Neel I. Nissen, et al.
Publicado: (2021) -
Prognostic Value of Sarcopenia in Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil
por: Mateusz Malik, et al.
Publicado: (2021) -
Circulating tumour cells at baseline and late phase of treatment provide prognostic value in breast cancer
por: Shuyun Pang, et al.
Publicado: (2021) -
The Prognostic Value of Circulating Tumor DNA in Ovarian Cancer: A Meta-Analysis
por: Yuanyuan Lu MD, et al.
Publicado: (2021) -
Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab
por: Torben Frøstrup Hansen, et al.
Publicado: (2017)